These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31582270)

  • 1. Artesunate enhances the immune response of rabies vaccine as an adjuvant.
    Luo J; Zhang Y; He H; Liu Q; Huang S; Guo X
    Vaccine; 2019 Dec; 37(51):7478-7481. PubMed ID: 31582270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant activity of PCP-II, a polysaccharide from Poria cocos, on a whole killed rabies vaccine.
    Zhang W; Cheng N; Wang Y; Zheng X; Zhao Y; Wang H; Wang C; Han Q; Gao Y; Shan J; Yang S; Xia X
    Virus Res; 2019 Sep; 270():197638. PubMed ID: 31173772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of interleukin-6 by a recombinant rabies virus enhances its immunogenicity as a potential vaccine.
    Luo J; Zhang B; Wu Y; Tian Q; Zhao J; Lyu Z; Zhang Q; Mei M; Luo Y; Guo X
    Vaccine; 2017 Feb; 35(6):938-944. PubMed ID: 28089546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of determination of rabies virus neutralizing antibody titres in the sera of vaccinated humans.].
    Butirskiy AY; Muhacheva AV; Movsesyants AA; Sarkisyan KA
    Vopr Virusol; 2019; 64(6):298-305. PubMed ID: 32168444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice.
    Kaur M; Saxena A; Rai A; Bhatnagar R
    FASEB J; 2010 Jan; 24(1):173-83. PubMed ID: 19741168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Immune Response to Rabies Viruses by the Use of a Liposome Adjuvant in Vaccines.
    Miao L; Yang Y; Yan M; Li Y; Zhao J; Guo J; Zheng D
    Viral Immunol; 2017 Dec; 30(10):727-733. PubMed ID: 28953450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A CpG oligodeoxynucleotide enhances the immune response to rabies vaccination in mice.
    Yu P; Yan J; Wu W; Tao X; Lu X; Liu S; Zhu W
    Virol J; 2018 Nov; 15(1):174. PubMed ID: 30424815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of C3d-P28 adjuvant to a rabies DNA vaccine encoding the G5 linear epitope enhances the humoral immune response and confers protection.
    Galvez-Romero G; Salas-Rojas M; Pompa-Mera EN; Chávez-Rueda K; Aguilar-Setién Á
    Vaccine; 2018 Jan; 36(2):292-298. PubMed ID: 29191739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoenhancement with flagellin as an adjuvant to whole-killed rabies vaccine in mice.
    Xiao XX; Zhang Y; Liu JX; Wei QL; Yin XP
    Arch Virol; 2016 Mar; 161(3):685-91. PubMed ID: 26650039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracerebral vaccination suppresses the spread of rabies virus in the mouse brain.
    Sunden Y; Yano S; Ishida S; Ochiai K; Umemura T
    Microbes Infect; 2010 Dec; 12(14-15):1163-9. PubMed ID: 20713172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus.
    Kang H; Qi Y; Wang H; Zheng X; Gao Y; Li N; Yang S; Xia X
    Viruses; 2015 Mar; 7(3):1134-52. PubMed ID: 25768031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A chimpanzee adenoviral vector-based rabies vaccine protects beagle dogs from lethal rabies virus challenge.
    Wang X; Fang Z; Xiong J; Yang K; Chi Y; Tang X; Ma L; Zhang R; Deng F; Lan K; Zhou D
    Virology; 2019 Oct; 536():32-38. PubMed ID: 31394410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of G2 Citric Acid-Based Dendrimer as an Adjuvant in Veterinary Rabies Vaccine.
    Asgary V; Shoari A; Afshar Moayad M; Shafiee Ardestani M; Bigdeli R; Ghazizadeh L; Khosravy MS; Panahnejad E; Janani A; Bashar R; Abedi M; Ahangari Cohan R
    Viral Immunol; 2018; 31(1):47-54. PubMed ID: 29328884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of a novel nanoemulsion adjuvant for rabies vaccine which stabilizes a Krebs cycle intermediate (SDH) in an animal model.
    Ze L; Zonglin L; Ya'Nan W; Shaohui S; Huijuan Y; Wei C; Li W; Liao G
    Hum Vaccin Immunother; 2019; 15(2):388-396. PubMed ID: 30299210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exhaustive Exercise Does Not Affect Humoral Immunity and Protection after Rabies Vaccination in a Mouse Model.
    Xia L; Li M; Zhang Y; Ruan J; Pei J; Shi J; Fu ZF; Zhao L; Zhou M; Tian D
    Virol Sin; 2018 Jun; 33(3):241-248. PubMed ID: 29594957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporating B cell activating factor (BAFF) into the membrane of rabies virus (RABV) particles improves the speed and magnitude of vaccine-induced antibody responses.
    Plummer JR; McGettigan JP
    PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007800. PubMed ID: 31725816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of a reduced-dose whole killed rabies vaccine is significantly enhanced by ISCOMATRIX™ adjuvant, Merck amorphous aluminum hydroxylphosphate sulfate (MAA) or a synthetic TLR9 agonist in rhesus macaques.
    DiStefano D; Antonello JM; Bett AJ; Medi MB; Casimiro DR; ter Meulen J
    Vaccine; 2013 Oct; 31(42):4888-93. PubMed ID: 23941913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isatis indigotica root polysaccharides as adjuvants for an inactivated rabies virus vaccine.
    Zhang W; Zheng X; Cheng N; Gai W; Xue X; Wang Y; Gao Y; Shan J; Yang S; Xia X
    Int J Biol Macromol; 2016 Jun; 87():7-15. PubMed ID: 26875535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of protective immunity by topic application of a recombinant adenovirus expressing rabies virus glycoprotein.
    Lees CY; Briggs DJ; Wu X; Davis RD; Moore SM; Gordon C; Xiang Z; Ertl HC; Tang DC; Fu ZF
    Vet Microbiol; 2002 Apr; 85(4):295-303. PubMed ID: 11856579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs.
    Shuai L; Wang X; Wen Z; Ge J; Wang J; Zhao D; Bu Z
    Antiviral Res; 2017 Oct; 146():36-44. PubMed ID: 28822816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.